Ciliary Body and Choroid Melanoma, Small Size Completed Phase 2 Trials for Agatolimod (DB15018)

Indication	Status	Phase
DBCOND0030836 (Ciliary Body and Choroid Melanoma, Small Size)	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00085189	Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma	Treatment	Agatolimod (DB15018) GP-100 antigen (DB14800) Incomplete Freund's adjuvant (DB17475) Tyrosinase (DB16626)